INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 446m ago
HOUSE PTR45m ago
SEC 13F45m ago
ROBINHOOD CHAIN45m ago
DE
Corporate insider

Delaney Mark E

SVP & Chief Commercial OfficerCIK 0001955265

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells0 / 1
Max Insider Score26
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
DE
Delaney Mark ESVP & Chief Commercial Officer
DGXQUEST DIAGNOSTICS INC
Grant or award
A—
1,586 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    QUEST DIAGNOSTICS INCSVP & Chief Commercial Officer · Nov 20, 2025
5
DE
Delaney Mark ESVP & Chief Commercial Officer
DGXQUEST DIAGNOSTICS INC
Tax withholding
F
$43K
205 sh
Feb 18, 2026
Feb 20, 2026
traded Feb 18, 2026
+2d
SEC FORM 4

Evidence

5
DE
Delaney Mark ESVP & Chief Commercial Officer
DGXQUEST DIAGNOSTICS INC
Tax withholding
F$48K
230 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

15
DE
Delaney Mark ESVP & Chief Commercial Officer
DGXQUEST DIAGNOSTICS INC
Small acquisition
L$2,753
15 sh
Jan 28, 2026Feb 20, 2026
traded Jan 28, 2026
+23dSEC FORM 4

Evidence

5
DE
Delaney Mark ESVP & Chief Commercial Officer
DGXQUEST DIAGNOSTICS INC
Grant or award
A—
7,332 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

0
DE
Delaney Mark ESVP & Chief Commercial Officer
DGXQUEST DIAGNOSTICS INC
Option exercise · 10b5-1 plan
M$14K
100 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence

0
DE
Delaney Mark ESVP & Chief Commercial Officer
DGXQUEST DIAGNOSTICS INC
Option exercise · 10b5-1 plan
M$14K
100 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence

26
DE
Delaney Mark ESVP & Chief Commercial Officer
DGXQUEST DIAGNOSTICS INC
Open-market sale · 10b5-1 plan
SELL$1.49M
7,946 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence

8
DE
Delaney Mark ESVP & Chief Commercial Officer
DGXQUEST DIAGNOSTICS INC
Option exercise · 10b5-1 plan
M$1.13M
7,846 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence

20
DE
Delaney Mark ESVP & Chief Commercial Officer
DGXQUEST DIAGNOSTICS INC
Option exercise · 10b5-1 plan
M$1.13M
7,846 sh
Nov 18, 2025Nov 20, 2025
traded Nov 18, 2025
+2dSEC FORM 4

Evidence